Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system.
Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system.
复制标题
DOI:
10.1038/s41467-021-24821-2
复制
发表时间:
2021-08-03
影响因子:
16.6
通讯作者:
Chiosis G
中科院分区:
文献类型:
--
作者:
Bolaender A;Zatorska D;He H;Joshi S;Sharma S;Digwal CS;Patel HJ;Sun W;Imber BS;Ochiana SO;Patel MR;Shrestha L;Shah SK;Wang S;Karimov R;Tao H;Patel PD;Martin AR;Yan P;Panchal P;Almodovar J;Corben A;Rimner A;Ginsberg SD;Lyashchenko S;Burnazi E;Ku A;Kalidindi T;Lee SG;Grkovski M;Beattie BJ;Zanzonico P;Lewis JS;Larson S;Rodina A;Pillarsetty N;Tabar V;Dunphy MP;Taldone T;Shimizu F;Chiosis G
Diseases are a manifestation of how thousands of proteins interact. In several diseases, such as cancer and Alzheimer’s disease, proteome-wide disturbances in protein-protein interactions are caused by alterations to chaperome scaffolds termed epichaperomes. Epichaperome-directed chemical probes may be useful for detecting and reversing defective chaperomes. Here we provide structural, biochemical, and functional insights into the discovery of epichaperome probes, with a focus on their use in central nervous system diseases. We demonstrate on-target activity and kinetic selectivity of a radiolabeled epichaperome probe in both cells and mice, together with a proof-of-principle in human patients in an exploratory single group assignment diagnostic study (ClinicalTrials.gov Identifier: NCT03371420). The clinical study is designed to determine the pharmacokinetic parameters and the incidence of adverse events in patients receiving a single microdose of the radiolabeled probe administered by intravenous injection. In sum, we introduce a discovery platform for brain-directed chemical probes that specifically modulate epichaperomes and provide proof-of-principle applications in their use in the detection, quantification, and modulation of the target in complex biological systems. Here, the authors show structural, biochemical, and functional insights into the discovery of epichaperome‐ directed chemical probes for use in central nervous system diseases. Probes emerging from this work have translated to human clinical studies in Alzheimer’s disease and cancer.
登录
查看更多内容
DOI:
10.1158/1078-0432.ccr-16-3151
发表时间:
2017-10-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Canella A;Welker AM;Yoo JY;Xu J;Abas FS;Kesanakurti D;Nagarajan P;Beattie CE;Sulman EP;Liu J;Gumin J;Lang FF;Gurcan MN;Kaur B;Sampath D;Puduvalli VK
通讯作者:
Puduvalli VK
影响因子:
3.5
作者:
Chiosis, G;Lucas, B;Rosen, N
通讯作者:
Rosen, N
影响因子:
4.6
作者:
Jhaveri, Komal L.;dos Anjos, Carlos H.;Modi, Shanu
通讯作者:
Modi, Shanu
影响因子:
64.5
作者:
Brennan CW;Verhaak RG;McKenna A;Campos B;Noushmehr H;Salama SR;Zheng S;Chakravarty D;Sanborn JZ;Berman SH;Beroukhim R;Bernard B;Wu CJ;Genovese G;Shmulevich I;Barnholtz-Sloan J;Zou L;Vegesna R;Shukla SA;Ciriello G;Yung WK;Zhang W;Sougnez C;Mikkelsen T;Aldape K;Bigner DD;Van Meir EG;Prados M;Sloan A;Black KL;Eschbacher J;Finocchiaro G;Friedman W;Andrews DW;Guha A;Iacocca M;O'Neill BP;Foltz G;Myers J;Weisenberger DJ;Penny R;Kucherlapati R;Perou CM;Hayes DN;Gibbs R;Marra M;Mills GB;Lander E;Spellman P;Wilson R;Sander C;Weinstein J;Meyerson M;Gabriel S;Laird PW;Haussler D;Getz G;Chin L;TCGA Research Network
通讯作者:
TCGA Research Network
DOI:
10.1038/s41568-018-0020-9
发表时间:
2018-09
期刊:
Nature reviews. Cancer
影响因子:
--
作者:
Joshi S;Wang T;Araujo TLS;Sharma S;Brodsky JL;Chiosis G
通讯作者:
Chiosis G